GRPN Earnings

GRPN reported its FY2025Q4 earnings on 2026-03-02, showcasing a revenue of against an estimate of 138.26M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.19 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following GRPN's FY2025Q4 earnings announcement on 2026-03-02, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, GRPN's stock price tends to shift by an average of +12.46% in the 10 days leading up to earnings and +19.77% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate GRPN’s annual revenue to reach 137.34M, while the EPS is projected at 0.16. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.23% and EPS estimates Revise Upward by 0.07% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between GRPN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.23%, while EPS estimates moved Revise Upward by 0.07% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GRPN's stock price typically moves by +12.46% in the 10 days before its earnings and +19.77% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.16 and revenue of 137.34M.

The earnings call reveals strong financial performance, with impressive growth in core categories and a significant increase in adjusted EBITDA and free cash flow. The company's strategic focus on a hyperlocal marketplace and improved customer conversion rates are positive indicators. The Q&A section highlights management's optimism and strategic initiatives, despite some lack of specificity in responses. The raised guidance for billings growth further supports a positive outlook. Overall, the combination of strong financial metrics, strategic initiatives, and raised guidance suggests a positive stock price movement in the short term.